High-volume centers in the USA saw positive results with Transanal Total Mesorectal Excision (TaTME) for rectal cancer. The study of 391 patients revealed low rates of local recurrence, high completion rates of TME specimens, and promising 3-year overall survival. These findings support the oncologic safety and perioperative benefits of TaTME when conducted by skilled surgeons in specialized centers.
Journal Article by Zewde MG, Peyser DK (…) Sylla P et 12 al. in Surg Endosc
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.